September 03, 2009
Valstar available again for treatment of bladder cancer
Valstar was voluntarily withdrawn from the U.S. market in 2002 due to a formulation issue with an inactive component. The reintroduction of Valstar follows the FDA's February 27, 2009 approval of a modified formulation of Valstar.
For more information call (800) 462-ENDO or visit www.endo.com.